<!DOCTYPE html><html><head><title>Stem cell for Organ Production</title>
            <link rel="stylesheet" href="../css/style.css">
            
<script>
/* THE CITADEL PROTOCOL */
document.addEventListener('contextmenu', event => event.preventDefault());
document.addEventListener('keydown', function(event) {
    if (event.ctrlKey && (event.key === 'c' || event.key === 'u' || event.key === 's' || event.key === 'p' || event.key === 'a')) {
        event.preventDefault();
    }
    if (event.key === 'F12' || (event.ctrlKey && event.shiftKey && event.key === 'I')) {
        event.preventDefault();
    }
});
document.ondragstart = function() { return false; };
</script>
<style>
    body {
        -webkit-user-select: none;
        -moz-user-select: none;
        -ms-user-select: none;
        user-select: none;
    }
    img { pointer-events: none; }
</style>
<meta name="robots" content="noindex, nofollow, noarchive">
<!-- WARNING: PROTECTED CONTENT -->

            </head>
            <body>
            <div class="sidebar"><h3>CODEX OF COSMOS</h3><ul><li><a href='../index.html'>HOME</a></li><br><li><strong>MASTER PAPERS</strong></li><li><a href='../01-Master-Papers/01-Volume-1-The-Physics.html'>01-Volume-1-The-Physics.md</a></li><li><a href='../01-Master-Papers/03-The-Matrix.html'>The 128-Type Matrix</a></li><li><a href='../01-Master-Papers/04-The-Controls.html'>The Control Room</a></li><li><a href='../01-Master-Papers/05-The-Pathology.html'>The Cost of Error</a></li><li><a href='../01-Master-Papers/07-The-Diet.html'>The Electro-Nutrient Protocol</a></li><li><a href='../01-Master-Papers/06-The-Fusion.html'>The Energy Solution</a></li><li><a href='../01-Master-Papers/08-Bibliography.html'>The Logic Bridge: Verified Science</a></li><li><a href='../01-Master-Papers/02-The-Compass.html'>The Metabolic Compass</a></li><li><a href='../01-Master-Papers/02-Volume-2-The-Archetypes.html'>The Osteo</a></li><li><a href='../01-Master-Papers/01-The-Merger.html'>The Placozoan-Algal Merger</a></li><li><a href='../01-Master-Papers/03-Volume-3-The-Pathology.html'>Viral3</a></li><li><a href='../01-Master-Papers/04-Volume-4-The-Origin.html'>Z4_Oxidative_Stress_CISS_Spin</a></li><br><li><strong>APPENDICES</strong></li><li><a href='../00-ARCHIVE/1.html'>1</a></li><li><a href='../00-ARCHIVE/ABio-cancer.html'>A Bio-cancer</a></li><li><a href='../00-ARCHIVE/A1_The_Cranial_Dynamo.html'>A1_The_Cranial_Dynamo</a></li><li><a href='../00-ARCHIVE/A2_Bone_as_Piezoelectric_Shield1.html'>A2_Bone_as_Piezoelectric_Shield (1)</a></li><li><a href='../00-ARCHIVE/A3_Charge_Asymmetry1.html'>A3_Charge_Asymmetry (1)</a></li><li><a href='../00-ARCHIVE/A4_Fascia_Conductive_Network.html'>A4_Fascia_Conductive_Network</a></li><li><a href='../00-ARCHIVE/AGINGASLOSSOFSEPARATION1.html'>AGING AS LOSS OF SEPARATION 1</a></li><li><a href='../00-ARCHIVE/ALL_FILES_LIST.html'>ALL_FILES_LIST.txt</a></li><li><a href='../00-ARCHIVE/ALL_RAW_CONTENT_MASTER_FILE.html'>ALL_RAW_CONTENT_MASTER_FILE.txt</a></li><li><a href='../00-ARCHIVE/ALL_RAW_CONTENT_MASTER_FILE_FULL.html'>ALL_RAW_CONTENT_MASTER_FILE_FULL.txt</a></li><li><a href='../00-ARCHIVE/ASFDAS.html'>ASFDAS</a></li><li><a href='../00-ARCHIVE/ATOPICDERMATITIS.html'>ATOPIC DERMATITIS</a></li><li><a href='../00-ARCHIVE/ATOPICDERMATITIS1.html'>ATOPIC DERMATITIS1</a></li><li><a href='../00-ARCHIVE/Abstract.html'>Abstract</a></li><li><a href='../00-ARCHIVE/AnElectrochemicalHypothesisforCancer.html'>An Electrochemical Hypothesis for Cancer</a></li><li><a href='../00-ARCHIVE/B2_Neurotransmitter_Sequence.html'>B2_Neurotransmitter_Sequence</a></li><li><a href='../00-ARCHIVE/B3_Placozoan_Split.html'>B3_Placozoan_Split</a></li><li><a href='../00-ARCHIVE/B4_PLP_Bottleneck.html'>B4_PLP_Bottleneck</a></li><li><a href='../00-ARCHIVE/BREASTCANCER.html'>BREAST CANCER</a></li><li><a href='../00-ARCHIVE/01.03-blood-type-hardware.html'>Blood Types as Metabolic Hardware</a></li><li><a href='../00-ARCHIVE/C1_Metabolic_Origins_Sexlessness.html'>C1_Metabolic_Origins_Sexlessness</a></li><li><a href='../00-ARCHIVE/C4_Neurochemistry_Hubris.html'>C4_Neurochemistry_Hubris</a></li><li><a href='../00-ARCHIVE/C5_ADHD_Dopamine_Failure1.html'>C5_ADHD_Dopamine_Failure (1)</a></li><li><a href='../00-ARCHIVE/CANCERDRAFT2.html'>CANCER DRAFT 2</a></li><li><a href='../00-ARCHIVE/Cancerdraft1.html'>Cancer draft 1</a></li><li><a href='../00-ARCHIVE/Cellgrowthgeneral.html'>Cell growth general</a></li><li><a href='../00-ARCHIVE/Choline.html'>Choline</a></li><li><a href='../00-ARCHIVE/Choline-final.html'>Choline - final</a></li><li><a href='../00-ARCHIVE/Choline1.html'>Choline1</a></li><li><a href='../00-ARCHIVE/Choline2.html'>Choline2</a></li><li><a href='../00-ARCHIVE/Choline3.html'>Choline3</a></li><li><a href='../00-ARCHIVE/Choline5.html'>Choline5</a></li><li><a href='../00-ARCHIVE/Choline6.html'>Choline6</a></li><li><a href='../00-ARCHIVE/ChronicKidneyDiseaseasaFailureofGlomerularOscillatoryHemodynamics.html'>Chronic Kidney Disease as a Failure of Glomerular </a></li><li><a href='../00-ARCHIVE/CoverLette2.html'>Cover Lette2</a></li><li><a href='../00-ARCHIVE/Coverletter.html'>Cover letter</a></li><li><a href='../00-ARCHIVE/D1_Cranial_Reversal_Maneuver.html'>D1_Cranial_Reversal_Maneuver</a></li><li><a href='../00-ARCHIVE/D2_4_Phasic_Metabolic_Diet.html'>D2_4_Phasic_Metabolic_Diet</a></li><li><a href='../00-ARCHIVE/D4_Grounding_Rod_Protocol.html'>D4_Grounding_Rod_Protocol</a></li><li><a href='../00-ARCHIVE/DIMENSIONALBIOPHYSICS-TITLEPAGE.html'>DIMENSIONAL BIOPHYSICS - TITLE PAGE</a></li><li><a href='../00-ARCHIVE/DOCI.html'>DOCI</a></li><li><a href='../00-ARCHIVE/DearEdito1.html'>Dear Edito1</a></li><li><a href='../00-ARCHIVE/DearEditor.html'>Dear Editor</a></li><li><a href='../00-ARCHIVE/DeficientCNSpHBufferingandtheGABAergicCollapseinSchizophrenia.html'>Deficient CNS pH Buffering and the GABAergic Colla</a></li><li><a href='../00-ARCHIVE/E1_Quantum_Zeno_Enzyme_Catalysis.html'>E1_Quantum_Zeno_Enzyme_Catalysis</a></li><li><a href='../00-ARCHIVE/E2_Proton_Tunneling_DNA.html'>E2_Proton_Tunneling_DNA</a></li><li><a href='../00-ARCHIVE/E3_Tryptophan_Excitonic_Wire.html'>E3_Tryptophan_Excitonic_Wire</a></li><li><a href='../00-ARCHIVE/E4_Microtubule_Coherence_Time.html'>E4_Microtubule_Coherence_Time</a></li><li><a href='../00-ARCHIVE/E5_Iron_Sulfur_Clusters.html'>E5_Iron_Sulfur_Clusters</a></li><li><a href='../00-ARCHIVE/FULL_LIBRARY_CONTENT_DUMP.html'>FULL_LIBRARY_CONTENT_DUMP.txt</a></li><li><a href='../00-ARCHIVE/Frontalis.html'>Frontalis</a></li><li><a href='../00-ARCHIVE/H1_Phloem_Waves.html'>H1_Phloem_Waves</a></li><li><a href='../00-ARCHIVE/H2_Root_Brain_Grounding.html'>H2_Root_Brain_Grounding</a></li><li><a href='../00-ARCHIVE/H3_Soil_External_Rumen.html'>H3_Soil_External_Rumen</a></li><li><a href='../00-ARCHIVE/HUBBLETENSION.html'>HUBBLE TENSION</a></li><li><a href='../00-ARCHIVE/Highlight2.html'>Highlight2</a></li><li><a href='../00-ARCHIVE/Highlights.html'>Highlights</a></li><li><a href='../00-ARCHIVE/I1_Depression_Membrane_Headroom.html'>I1_Depression_Membrane_Headroom</a></li><li><a href='../00-ARCHIVE/I2_Anxiety_High_Gain_Noise.html'>I2_Anxiety_High_Gain_Noise</a></li><li><a href='../00-ARCHIVE/I3_Bipolar_Phase_Lock.html'>I3_Bipolar_Phase_Lock</a></li><li><a href='../00-ARCHIVE/Itstripsawaythemedicalapplications.html'>It strips away the medical applications</a></li><li><a href='../00-ARCHIVE/J3_Retrotransposon_Viral_Wake.html'>J3_Retrotransposon_Viral_Wake</a></li><li><a href='../00-ARCHIVE/J5_CRISPR_Target_Shielding.html'>J5_CRISPR_Target_Shielding</a></li><li><a href='../00-ARCHIVE/JOURNALOFEVOLUTIONARYBIOLOGY.html'>JOURNAL OF EVOLUTIONARY BIOLOGY</a></li><li><a href='../00-ARCHIVE/Journal_of_Evolutionary_Biology_Submission.html'>Journal_of_Evolutionary_Biology_Submission</a></li><li><a href='../00-ARCHIVE/LONGCOVID.html'>LONG COVID</a></li><li><a href='../00-ARCHIVE/Lifewasfirstcreatedthroughastruggleagainstauniversalforceinourunivers1.html'>Life was first created through a struggle against </a></li><li><a href='../00-ARCHIVE/Lifewasfirstcreatedthroughastruggleagainstauniversalforceinouruniverse-2.html'>Life was first created through a struggle against </a></li><li><a href='../00-ARCHIVE/MIGRAINE.html'>MIGRAINE</a></li><li><a href='../00-ARCHIVE/MelanomaasaFailureofBio.html'>Melanoma as a Failure of Bio</a></li><li><a href='../00-ARCHIVE/OlfactoryHallucinationsasBiomarkersofNeuralAutophagy.html'>Olfactory Hallucinations as Biomarkers of Neural A</a></li><li><a href='../00-ARCHIVE/OrthogonalFieldModulationofNitrogenaseElectronFluxANovelStrategyforEnhancedBiohydrogenProduction.html'>Orthogonal Field Modulation of Nitrogenase Electro</a></li><li><a href='../00-ARCHIVE/OsteoporosisasaChrono.html'>Osteoporosis as a Chrono</a></li><li><a href='../00-ARCHIVE/PAPER3.html'>PAPER 3</a></li><li><a href='../00-ARCHIVE/PARKINSONS.html'>PARKINSONS</a></li><li><a href='../00-ARCHIVE/PDAC.html'>PDAC</a></li><li><a href='../00-ARCHIVE/Paper_1_Container_Principle_Scientific.html'>Paper_1_Container_Principle_Scientific.txt</a></li><li><a href='../00-ARCHIVE/Paper_1_Scientific_Protocol_Only.html'>Paper_1_Scientific_Protocol_Only</a></li><li><a href='../00-ARCHIVE/Paper_2_The_Three_Solutions.html'>Paper_2_The_Three_Solutions</a></li><li><a href='../00-ARCHIVE/Paper_3_Atmospheric_Interface_Protocol.html'>Paper_3_Atmospheric_Interface_Protocol</a></li><li><a href='../00-ARCHIVE/Paper_3_The_Invisible_Hand.html'>Paper_3_The_Invisible_Hand</a></li><li><a href='../00-ARCHIVE/Paper_4_The_Tearing_Mode_Solved.html'>Paper_4_The_Tearing_Mode_Solved</a></li><li><a href='../00-ARCHIVE/Placozoan.html'>Placozoan</a></li><li><a href='../00-ARCHIVE/QUANTUMTELEPORTATIO2.html'>QUANTUM TELEPORTATIO2</a></li><li><a href='../00-ARCHIVE/QUANTUMTELEPORTATION.html'>QUANTUM TELEPORTATION</a></li><li><a href='../00-ARCHIVE/QUANTUMTELEPORTATION1.html'>QUANTUM TELEPORTATION1</a></li><li><a href='../00-ARCHIVE/SCHIZOPHRENIA4.html'>SCHIZOPHRENIA 4</a></li><li><a href='../00-ARCHIVE/Schizophreniaasanα2.html'>Schizophrenia as an α2</a></li><li><a href='../00-ARCHIVE/StemcellforOrganProduction.html'>Stem cell for Organ Production</a></li><li><a href='../00-ARCHIVE/SuddenInfantDeathSyndromeasaTransientFailureofChrono.html'>Sudden Infant Death Syndrome as a Transient Failur</a></li><li><a href='../00-ARCHIVE/SuicideasaThermodynamicFailureofthe.html'>Suicide as a Thermodynamic Failure of the</a></li><li><a href='../00-ARCHIVE/SystemicLupusErythematosusasaFailureofLymphaticClearance.html'>Systemic Lupus Erythematosus as a Failure of Lymph</a></li><li><a href='../00-ARCHIVE/THEELECTROCHEMICALORIGINSOFLIF1.html'>THE ELECTROCHEMICAL ORIGINS OF LIF1</a></li><li><a href='../00-ARCHIVE/THEELECTROCHEMICALORIGINSOFLIFE.html'>THE ELECTROCHEMICAL ORIGINS OF LIFE</a></li><li><a href='../00-ARCHIVE/THEORTHOGONALREDOXSWITCH.html'>THE ORTHOGONAL REDOX SWITCH</a></li><li><a href='../00-ARCHIVE/THEVIBRATIONALGATINGOFTHERHIZOSPHERE.html'>THE VIBRATIONAL GATING OF THE RHIZOSPHERE</a></li><li><a href='../00-ARCHIVE/4.01-the-sexual-metabolism.html'>Testosterone and Estrogen: The Retaliation Pair</a></li><li><a href='../00-ARCHIVE/TheAcidShield.html'>The Acid Shield</a></li><li><a href='../00-ARCHIVE/TheAcidShield1.html'>The Acid Shield(1)</a></li><li><a href='../00-ARCHIVE/TheAntioxidantParadox.html'>The Antioxidant Paradox</a></li><li><a href='../00-ARCHIVE/TheBreastasanEntropyTrap.html'>The Breast as an Entropy Trap</a></li><li><a href='../00-ARCHIVE/TheBreastasanEntropyTrap1.html'>The Breast as an Entropy Trap1</a></li><li><a href='../00-ARCHIVE/TheChrono.html'>The Chrono</a></li><li><a href='../00-ARCHIVE/TheCollapseoftheClimbingCurrent-PARKINSONS.html'>The Collapse of the Climbing Current - PARKINSON'S</a></li><li><a href='../00-ARCHIVE/TheCranialArc.html'>The Cranial Arc</a></li><li><a href='../00-ARCHIVE/TheGABAergicShieldLoss.html'>The GABAergic Shield Loss</a></li><li><a href='../00-ARCHIVE/TheGeometricDescentandtheMetabolicAscen1.html'>The Geometric Descent and the Metabolic Ascen1</a></li><li><a href='../00-ARCHIVE/TheGeometricDescentandtheMetabolicAscent.html'>The Geometric Descent and the Metabolic Ascent</a></li><li><a href='../00-ARCHIVE/TheGlutamatergicOverloadHypothesisofAmyotrophicLateralSclerosi1.html'>The Glutamatergic Overload Hypothesis of Amyotroph</a></li><li><a href='../00-ARCHIVE/TheGlutamatergicOverloadHypothesisofAmyotrophicLateralSclerosis.html'>The Glutamatergic Overload Hypothesis of Amyotroph</a></li><li><a href='../00-ARCHIVE/TheInternalizedStressPhenotypeABO.html'>The Internalized Stress Phenotype ABO</a></li><li><a href='../00-ARCHIVE/TheLactate-GABAShuttleHypothesis.html'>The Lactate-GABA Shuttle Hypothesis</a></li><li><a href='../00-ARCHIVE/02.01-mechanism-of-collapse.html'>The Mechanism of Dimensional Collapse</a></li><li><a href='../00-ARCHIVE/TheNeuralAr1.html'>The Neural Ar1</a></li><li><a href='../00-ARCHIVE/TheNeuralArc.html'>The Neural Arc</a></li><li><a href='../00-ARCHIVE/01.02-dimensional-evolution.html.html'>The Neurotransmitter Evolutionary Sequence</a></li><li><a href='../00-ARCHIVE/TheOsteo.html'>The Osteo</a></li><li><a href='../00-ARCHIVE/TheOsteoporosis.html'>The Osteoporosis</a></li><li><a href='../00-ARCHIVE/TheRazo1.html'>The Razo1</a></li><li><a href='../00-ARCHIVE/TheRazor.html'>The Razor</a></li><li><a href='../00-ARCHIVE/TheRazor1.html'>The Razor(1)</a></li><li><a href='../00-ARCHIVE/01.01-thermodynamic-origins.html.html'>The Thermodynamic Origin of Life</a></li><li><a href='../00-ARCHIVE/TheTriadofCollapse-ALS.html'>The Triad of Collapse -ALS</a></li><li><a href='../00-ARCHIVE/The-ALS_Amyotrophic_Lateral_Sclerosis_Scientific_Protocol.html'>The-ALS_(Amyotrophic_Lateral_Sclerosis)_Scientific</a></li><li><a href='../00-ARCHIVE/The-Acne_Vulgaris_Triad.html'>The-Acne_Vulgaris_Triad</a></li><li><a href='../00-ARCHIVE/The-Adrenal_Burnout_HPA_Axis_Dysregulation_Scientific_Protocol.html'>The-Adrenal_Burnout_(HPA_Axis_Dysregulation)_Scien</a></li><li><a href='../00-ARCHIVE/The-Alzheimers_Disease_Type_3_Diabetes_Scientific_Protocol.html'>The-Alzheimer's_Disease_(Type_3_Diabetes)_Scientif</a></li><li><a href='../00-ARCHIVE/The-Androgenetic_Alopecia_Male_Pattern_Baldness_Scientific_Protocol.html'>The-Androgenetic_Alopecia_(Male_Pattern_Baldness)_</a></li><li><a href='../00-ARCHIVE/The-Asthma_Scientific_Protocol.html'>The-Asthma_Scientific_Protocol</a></li><li><a href='../00-ARCHIVE/The-Autism_Spectrum_Gut-Brain_Scientific_Protocol.html'>The-Autism_Spectrum_(Gut-Brain)_Scientific_Protoco</a></li><li><a href='../00-ARCHIVE/The-Bipolar_Disorder_Scientific_Protocol.html'>The-Bipolar_Disorder_Scientific_Protocol</a></li><li><a href='../00-ARCHIVE/The-Brain_Zaps_SSRI_Withdrawal_Scientific_Protocol.html'>The-Brain_Zaps_(SSRI_Withdrawal)_Scientific_Protoc</a></li><li><a href='../00-ARCHIVE/The-Breast_Cancer_Prevention_Scientific_Protocol.html'>The-Breast_Cancer_(Prevention)_Scientific_Protocol</a></li><li><a href='../00-ARCHIVE/The-Bruxism_Sleep_Grinding_Scientific_Protocol.html'>The-Bruxism_(Sleep_Grinding)_Scientific_Protocol</a></li><li><a href='../00-ARCHIVE/The-Burning_Mouth_Syndrome_Scientific_Protocol.html'>The-Burning_Mouth_Syndrome_Scientific_Protocol</a></li><li><a href='../00-ARCHIVE/The-Cancer_General_Metabolic_Support_Scientific_Protocol.html'>The-Cancer_(General_Metabolic_Support)_Scientific_</a></li><li><a href='../00-ARCHIVE/The-Chronic_Fatigue_Syndrome_MECFS_Scientific_Protocol.html'>The-Chronic_Fatigue_Syndrome_(MECFS)_Scientific_Pr</a></li><li><a href='../00-ARCHIVE/The-Cold_Urticaria_Allergy_to_Cold_Scientific_Protocol.html'>The-Cold_Urticaria_(Allergy_to_Cold)_Scientific_Pr</a></li><li><a href='../00-ARCHIVE/The-Colon_Cancer_Prevention_Scientific_Protocol.html'>The-Colon_Cancer_(Prevention)_Scientific_Protocol</a></li><li><a href='../00-ARCHIVE/The-Costochondritis_Chest_Wall_Pain_Scientific_Protocol.html'>The-Costochondritis_(Chest_Wall_Pain)_Scientific_P</a></li><li><a href='../00-ARCHIVE/The-Crohns_Disease_Scientific_Protocol.html'>The-Crohn's_Disease_Scientific_Protocol</a></li><li><a href='../00-ARCHIVE/The-Dry_Eye_Syndrome_Scientific_Protocol.html'>The-Dry_Eye_Syndrome_Scientific_Protocol</a></li><li><a href='../00-ARCHIVE/The-Eczema_Atopic_Dermatitis_Scientific_Protocol.html'>The-Eczema_(Atopic_Dermatitis)_Scientific_Protocol</a></li><li><a href='../00-ARCHIVE/The-Endometriosis_Triad.html'>The-Endometriosis_Triad</a></li><li><a href='../00-ARCHIVE/The-Erectile_Dysfunction_Triad.html'>The-Erectile_Dysfunction_Triad</a></li><li><a href='../00-ARCHIVE/The-Fibromyalgia_Scientific_Protocol.html'>The-Fibromyalgia_Scientific_Protocol</a></li><li><a href='../00-ARCHIVE/The-Fibromyalgia_Triad.html'>The-Fibromyalgia_Triad</a></li><li><a href='../00-ARCHIVE/The-Frozen_Shoulder_Adhesive_Capsulitis_Scientific_Protocol.html'>The-Frozen_Shoulder_(Adhesive_Capsulitis)_Scientif</a></li><li><a href='../00-ARCHIVE/The-Geographic_Tongue_Scientific_Protocol.html'>The-Geographic_Tongue_Scientific_Protocol</a></li><li><a href='../00-ARCHIVE/The-Gingivitis_Scientific_Protocol.html'>The-Gingivitis_Scientific_Protocol</a></li><li><a href='../00-ARCHIVE/The-Glaucoma_Low_Tension_Triad.html'>The-Glaucoma_(Low_Tension)_Triad</a></li><li><a href='../00-ARCHIVE/The-Glioblastoma_GBM_Scientific_Protocol.html'>The-Glioblastoma_(GBM)_Scientific_Protocol</a></li><li><a href='../00-ARCHIVE/The-Gout_Triad.html'>The-Gout_Triad</a></li><li><a href='../00-ARCHIVE/The-Graves_Disease_Scientific_Protocol.html'>The-Graves'_Disease_Scientific_Protocol</a></li><li><a href='../00-ARCHIVE/The-HIV_Retrovirus_Scientific_Protocol.html'>The-HIV_(Retrovirus)_Scientific_Protocol</a></li><li><a href='../00-ARCHIVE/The-Hangover_Alcohol_Toxicity_Scientific_Protocol.html'>The-Hangover_(Alcohol_Toxicity)_Scientific_Protoco</a></li><li><a href='../00-ARCHIVE/The-Hashimotos_Thyroiditis_Scientific_Protocol.html'>The-Hashimoto's_Thyroiditis_Scientific_Protocol</a></li><li><a href='../00-ARCHIVE/The-Herniated_Disc_Scientific_Protocol.html'>The-Herniated_Disc_Scientific_Protocol</a></li><li><a href='../00-ARCHIVE/The-Histamine_Intolerance_HIT_Scientific_Protocol.html'>The-Histamine_Intolerance_(HIT)_Scientific_Protoco</a></li><li><a href='../00-ARCHIVE/The-Hypothyroidism_Hashimotos_Triad.html'>The-Hypothyroidism_(Hashimoto's)_Triad</a></li><li><a href='../00-ARCHIVE/The-Insomnia_Triad.html'>The-Insomnia_Triad</a></li><li><a href='../00-ARCHIVE/The-Interstitial_Cystitis_Painful_Bladder_Scientific_Protocol.html'>The-Interstitial_Cystitis_(Painful_Bladder)_Scient</a></li><li><a href='../00-ARCHIVE/The-Irritable_Bowel_Syndrome_IBS_Scientific_Protocol.html'>The-Irritable_Bowel_Syndrome_(IBS)_Scientific_Prot</a></li><li><a href='../00-ARCHIVE/The-Jet_Lag_Scientific_Protocol.html'>The-Jet_Lag_Scientific_Protocol</a></li><li><a href='../00-ARCHIVE/The-Kyphosis_Hunchback_Scientific_Protocol.html'>The-Kyphosis_(Hunchback)_Scientific_Protocol</a></li><li><a href='../00-ARCHIVE/The-Laryngopharyngeal_Reflux_Silent_Reflux_Scientific_Protocol.html'>The-Laryngopharyngeal_Reflux_(Silent_Reflux)_Scien</a></li><li><a href='../00-ARCHIVE/The-Long_COVID_PASC_Scientific_Protocol.html'>The-Long_COVID_(PASC)_Scientific_Protocol</a></li><li><a href='../00-ARCHIVE/The-Low_Libido_Hypoactive_Sexual_Desire_Scientific_Protocol.html'>The-Low_Libido_(Hypoactive_Sexual_Desire)_Scientif</a></li><li><a href='../00-ARCHIVE/The-Lupus_SLE_Scientific_Protocol.html'>The-Lupus_(SLE)_Scientific_Protocol</a></li><li><a href='../00-ARCHIVE/The-Lyme_Disease_Chronic_Scientific_Protocol.html'>The-Lyme_Disease_(Chronic)_Scientific_Protocol</a></li><li><a href='../00-ARCHIVE/The-Macular_Degeneration_AMD_Triad.html'>The-Macular_Degeneration_(AMD)_Triad</a></li><li><a href='../00-ARCHIVE/The-Malaria_Plasmodium_Scientific_Protocol.html'>The-Malaria_(Plasmodium)_Scientific_Protocol</a></li><li><a href='../00-ARCHIVE/The-Misophonia_Sound_Rage_Scientific_Protocol.html'>The-Misophonia_(Sound_Rage)_Scientific_Protocol</a></li><li><a href='../00-ARCHIVE/The-Motion_Sickness_Scientific_Protocol.html'>The-Motion_Sickness_Scientific_Protocol</a></li><li><a href='../00-ARCHIVE/The-Mouth_Breathing_Chronic_Scientific_Protocol.html'>The-Mouth_Breathing_(Chronic)_Scientific_Protocol</a></li><li><a href='../00-ARCHIVE/The-Multiple_Sclerosis_MS_Scientific_Protocol.html'>The-Multiple_Sclerosis_(MS)_Scientific_Protocol</a></li><li><a href='../00-ARCHIVE/The-Multiple_Sclerosis_Triad.html'>The-Multiple_Sclerosis_Triad</a></li><li><a href='../00-ARCHIVE/The-Myopia_Nearsightedness_Scientific_Protocol.html'>The-Myopia_(Nearsightedness)_Scientific_Protocol</a></li><li><a href='../00-ARCHIVE/The-Night_Sweats_Scientific_Protocol.html'>The-Night_Sweats_Scientific_Protocol</a></li><li><a href='../00-ARCHIVE/The-POTS_Postural_Orthostatic_Tachycardia_Scientific_Protocol.html'>The-POTS_(Postural_Orthostatic_Tachycardia)_Scient</a></li><li><a href='../00-ARCHIVE/The-Parkinsons_Disease_Scientific_Protocol.html'>The-Parkinson's_Disease_Scientific_Protocol</a></li><li><a href='../00-ARCHIVE/The-Parkinsons_Disease_Triad.html'>The-Parkinson's_Disease_Triad</a></li><li><a href='../00-ARCHIVE/The-Polycystic_Ovary_Syndrome_PCOS_Triad.html'>The-Polycystic_Ovary_Syndrome_(PCOS)_Triad</a></li><li><a href='../00-ARCHIVE/The-Prostate_Cancer_Support_Scientific_Protocol.html'>The-Prostate_Cancer_(Support)_Scientific_Protocol</a></li><li><a href='../00-ARCHIVE/The-Psoriasis_Scientific_Protocol.html'>The-Psoriasis_Scientific_Protocol</a></li><li><a href='../00-ARCHIVE/The-Psoriasis_Triad.html'>The-Psoriasis_Triad</a></li><li><a href='../00-ARCHIVE/The-Restless_Leg_Syndrome_RLS_Scientific_Protocol.html'>The-Restless_Leg_Syndrome_(RLS)_Scientific_Protoco</a></li><li><a href='../00-ARCHIVE/The-Rheumatoid_Arthritis_RA_Scientific_Protocol.html'>The-Rheumatoid_Arthritis_(RA)_Scientific_Protocol</a></li><li><a href='../00-ARCHIVE/The-Schizophrenia_Metabolic_Scientific_Protocol.html'>The-Schizophrenia_(Metabolic)_Scientific_Protocol</a></li><li><a href='../00-ARCHIVE/The-Sciatica_Scientific_Protocol.html'>The-Sciatica_Scientific_Protocol</a></li><li><a href='../00-ARCHIVE/The-Scoliosis_Scientific_Protocol.html'>The-Scoliosis_Scientific_Protocol</a></li><li><a href='../00-ARCHIVE/The-Sjogrens_Syndrome_Scientific_Protocol.html'>The-Sjogren's_Syndrome_Scientific_Protocol</a></li><li><a href='../00-ARCHIVE/The-Sjogrens_Syndrome_Triad.html'>The-Sjogren's_Syndrome_Triad</a></li><li><a href='../00-ARCHIVE/The-Skin_Aging_Wrinkles_Scientific_Protocol.html'>The-Skin_Aging_(Wrinkles)_Scientific_Protocol</a></li><li><a href='../00-ARCHIVE/The-Sleep_Apnea_Obstructive_Scientific_Protocol.html'>The-Sleep_Apnea_(Obstructive)_Scientific_Protocol</a></li><li><a href='../00-ARCHIVE/The-Sleep_Apnea_Obstructive_Triad.html'>The-Sleep_Apnea_(Obstructive)_Triad</a></li><li><a href='../00-ARCHIVE/The-Small_Intestinal_Bacterial_Overgrowth_SIBO_Scientific_Protocol.html'>The-Small_Intestinal_Bacterial_Overgrowth_(SIBO)_S</a></li><li><a href='../00-ARCHIVE/The-Snoring_Scientific_Protocol.html'>The-Snoring_Scientific_Protocol</a></li><li><a href='../00-ARCHIVE/The-Tinnitus_Scientific_Protocol.html'>The-Tinnitus_Scientific_Protocol</a></li><li><a href='../00-ARCHIVE/The-Tinnitus_Triad.html'>The-Tinnitus_Triad</a></li><li><a href='../00-ARCHIVE/The-Tuberculosis_Mycobacterium_Scientific_Protocol.html'>The-Tuberculosis_(Mycobacterium)_Scientific_Protoc</a></li><li><a href='../00-ARCHIVE/The-Tumor_Lysis_Cancer_Scientific_Protocol.html'>The-Tumor_Lysis_(Cancer)_Scientific_Protocol</a></li><li><a href='../00-ARCHIVE/The-Ulcerative_Colitis_Scientific_Protocol.html'>The-Ulcerative_Colitis_Scientific_Protocol</a></li><li><a href='../00-ARCHIVE/The-Ulcerative_Colitis_Triad.html'>The-Ulcerative_Colitis_Triad</a></li><li><a href='../00-ARCHIVE/The-Vertigo_BPPV_Scientific_Protocol.html'>The-Vertigo_(BPPV)_Scientific_Protocol</a></li><li><a href='../00-ARCHIVE/The-Vertigo_BPPV_Menieres_Triad.html'>The-Vertigo_(BPPV_Meniere's)_Triad</a></li><li><a href='../00-ARCHIVE/The-Visual_Snow_Syndrome_Scientific_Protocol.html'>The-Visual_Snow_Syndrome_Scientific_Protocol</a></li><li><a href='../00-ARCHIVE/The-Zika_Virus_Scientific_Protocol.html'>The-Zika_Virus_Scientific_Protocol</a></li><li><a href='../00-ARCHIVE/Title.html'>Title</a></li><li><a href='../00-ARCHIVE/Title1.html'>Title1</a></li><li><a href='../00-ARCHIVE/Title2.html'>Title2</a></li><li><a href='../00-ARCHIVE/TotheEditor.html'>To the Editor</a></li><li><a href='../00-ARCHIVE/VertexOverloa1.html'>Vertex Overloa1</a></li><li><a href='../00-ARCHIVE/VertexOverload.html'>Vertex Overload</a></li><li><a href='../00-ARCHIVE/Viral.html'>Viral</a></li><li><a href='../00-ARCHIVE/Viral1.html'>Viral1</a></li><li><a href='../00-ARCHIVE/Viral2.html'>Viral2</a></li><li><a href='../00-ARCHIVE/Viral3.html'>Viral3</a></li><li><a href='../communication/2025-12-07-intro.html'>Why I Created This Framework</a></li><li><a href='../00-ARCHIVE/Y1_AI_Server_Cooling_Fever.html'>Y1_AI_Server_Cooling_Fever</a></li><li><a href='../00-ARCHIVE/Y2_Battery_Degradation_Sclerosis.html'>Y2_Battery_Degradation_Sclerosis</a></li><li><a href='../00-ARCHIVE/Y3_Desalination_Burnout_Osmosis.html'>Y3_Desalination_Burnout_Osmosis</a></li><li><a href='../00-ARCHIVE/Z4_Oxidative_Stress_CISS_Spin.html'>Z4_Oxidative_Stress_CISS_Spin</a></li><li><a href='../00-ARCHIVE/agingpart2.html'>aging part2</a></li><li><a href='../00-ARCHIVE/alzheimers3.html'>alzheimers3</a></li><li><a href='../00-ARCHIVE/asdfa.html'>asdfa</a></li><li><a href='../00-ARCHIVE/bioenergeticsandmetabolism.html'>bioenergetics and metabolism</a></li><li><a href='../00-ARCHIVE/breastcancerdraft.html'>breast cancer draft</a></li><li><a href='../00-ARCHIVE/cancerBiophysics.html'>cancer Biophysics</a></li><li><a href='../00-ARCHIVE/cancerandmetabolism.html'>cancer and metabolism</a></li><li><a href='../00-ARCHIVE/choline4.html'>choline4</a></li><li><a href='../00-ARCHIVE/claude2.html'>claude2</a></li><li><a href='../00-ARCHIVE/climatechange4.html'>climate change 4</a></li><li><a href='../00-ARCHIVE/gabaergicshieldloss2.html'>gabaergic shield loss 2</a></li><li><a href='../00-ARCHIVE/glaucoma.html'>glaucoma</a></li><li><a href='../00-ARCHIVE/gppcover.html'>gpp cover</a></li><li><a href='../00-ARCHIVE/highlight4.html'>highlight4</a></li><li><a href='../00-ARCHIVE/melanoma.html'>melanoma</a></li><li><a href='../00-ARCHIVE/quantumcomputing.html'>quantum computing</a></li><li><a href='../00-ARCHIVE/quantumcomputingnotes.html'>quantum computing notes</a></li></ul></div>
            <div class="main-content">
                <h1>Stem cell for Organ Production</h1>
<p>Core axes that define an organ</p>
<p>Instead of starting from anatomy words (“heart,” “liver”), start from what the tissue does to energy and matter:</p>
<p>Pump vs. filter vs. store vs. sense.</p>
<p>Pump (heart, gut smooth muscle): cyclic force and conduction.</p>
<p>Filter (kidney, liver): continuous high flow, selective transport, enzyme density.</p>
<p>Store (fat, bone marrow): low flow, high reduction (anabolic).</p>
<p>Sense/compute (brain, retina): high information, low mechanical load.​</p>
<p>Oxidative vs. reductive bias.</p>
<p>Heart and kidney run very high oxidative flux; liver and marrow have large reductive “build” capacity.​</p>
<p>Mechanical environment.</p>
<p>Heart and large vessels live in a high-strain cyclic field; cartilage and bone live in compression; gut epithelium in shear and stretch; brain in near-zero strain.​</p>
<p>Architecture.</p>
<p>Heart: anisotropic fibers + syncytium.</p>
<p>Kidney: parallel tubules and glomerular filters.</p>
<p>Liver: radial lobules around central veins.</p>
<p>Intestine: crypt–villus axis.​</p>
<p>Each “archetype” is then a recipe for what the bioreactor must feel like: how soft, how oxygenated, how rhythmic, how directional.</p>
<p>Turning archetypes into knobs you can set</p>
<p>For each organ, you can read off a parameter set:</p>
<p>Oxygen &amp; flow.</p>
<p>High-demand pump/filter organs (heart, kidney) need high and very stable oxygen delivery in vitro; heart constructs mature better under perfusion and electrical pacing than in static gels.​</p>
<p>More reductive, builder organs (liver, marrow-like stromal tissues) tolerate and often prefer mild hypoxia that supports stemness and anabolic metabolism.​</p>
<p>Stiffness &amp; ECM.</p>
<p>Heart and skeletal muscle: soft–to–intermediate (∼10–20 kPa) anisotropic scaffolds with collagen I, laminin.​</p>
<p>Liver: very soft (∼0.5–2 kPa) viscoelastic hydrogels with abundant collagen IV and laminin to support hepatocyte polarity and bile canaliculi.​</p>
<p>Cartilage/bone: stiffer, mineralizable or proteoglycan-rich scaffolds.​</p>
<p>Dynamic cues.</p>
<p>Heart: 1–2 Hz electrical and mechanical pacing during maturation improves conduction and contractile force.​</p>
<p>Gut epithelium: luminal shear + cyclic stretch supports correct crypt–villus organization and barrier function.​</p>
<p>Brain organoids: minimal mechanical strain, carefully controlled oxygen and nutrient delivery in spinning/rocking bioreactors.​</p>
<p>Morphogen sets.</p>
<p>Each lineage uses a known combination of Wnt, BMP, FGF, TGF-β, Notch timing to specify region and identity; organoid protocols for intestine, liver, kidney, brain already encode these sequences.​</p>
<ol>
<li>Cell source</li>
</ol>
<p>Preferred: Clinical-grade human iPSC-derived cardiomyocytes (hiPSC-CMs), plus supportive cardiac fibroblasts and endothelial cells for better tissue architecture and vascularization potential.​</p>
<p>Quality:</p>
<p>Derive or obtain hiPSC lines under GMP or equivalent guidelines.​</p>
<p>Confirm normal karyotype and absence of known oncogenic mutations in master cell bank.​</p>
<ol>
<li>Scaffold: “Heart-like” Mechanical and Structural Design</li>
</ol>
<p>Bulk material: Biodegradable elastomer such as poly(glycerol sebacate) (PGS), GelMA, or similar elastomeric hydrogel with Young’s modulus in the ∼10–50 kPa range to approximate myocardium stiffness.​</p>
<p>Micro-architecture:</p>
<p>Microfabricated grooves or aligned pores (∼10–50 µm) to orient cardiomyocytes along a single axis, promoting anisotropic conduction and contraction.​</p>
<p>High porosity to allow cell infiltration and nutrient flow.​</p>
<p>Surface treatment: Coat with ECM proteins (collagen I, fibronectin, laminin) to promote adhesion and spreading of hiPSC-CMs and supporting cells.​</p>
<ol>
<li>Medium and Growth Factors</li>
</ol>
<p>3.1 Seeding and early expansion (days 0–3)</p>
<p>Base medium: RPMI-B27 or similar cardiomyocyte medium (glucose, amino acids, vitamins, insulin, transferrin).</p>
<p>Supplements:</p>
<p>Insulin-like Growth Factor-1 (IGF-1, ~50–100 ng/mL) to enhance viability, growth and early hypertrophy.​</p>
<p>Ascorbic acid (50–100 µg/mL) to support collagen synthesis and antioxidant defense.​</p>
<p>Conditions:</p>
<p>Static culture or very low-shear perfusion to allow cell attachment and spreading in the scaffold.​</p>
<p>3.2 Maturation phase (after day 3)</p>
<p>Continue base medium; maintain IGF-1 during early maturation to support survival and structural development.​</p>
<p>Optionally taper IGF-1 later to restrict uncontrolled hypertrophy, while maintaining ascorbic acid and metabolic support.</p>
<ol>
<li>Electrical and Mechanical Stimulation</li>
</ol>
<p>Heart is defined by rhythmic excitation and contraction, so these cues are essential.</p>
<p>4.1 Electrical pacing</p>
<p>Begin pacing around day 3 after seeding, once cells are attached.​</p>
<p>Typical protocol (from PGS scaffold study):​</p>
<p>Monophasic square pulses</p>
<p>2 ms duration</p>
<p>5 V/cm field strength</p>
<p>1 Hz frequency</p>
<p>Effects observed: improved connexin-43 expression, better sarcomere organization, lower excitation threshold, and stronger synchronous contractions.​</p>
<p>4.2 Mechanical conditioning</p>
<p>If the bioreactor allows, apply cyclic stretch (5–10% strain) at or near the pacing frequency to mimic systolic–diastolic cycles.​</p>
<p>This further improves alignment, force generation, and extracellular matrix organization in many cardiac tissue-engineering systems.​</p>
<ol>
<li>Bioreactor Environment</li>
</ol>
<p>Configuration:</p>
<p>Low-shear perfusion or flow-through bioreactor with integrated electrodes for pacing (several designs are published and open-source).​</p>
<p>Oxygen:</p>
<p>Maintain near-physiological oxygen (∼5–21% O) with good mixing to avoid hypoxic cores; high metabolic demand of cardiomyocytes makes oxygen control critical.​</p>
<p>Flow:</p>
<p>Provide continuous low-shear medium perfusion across the construct to supply nutrients and remove waste; adjust flow rates to prevent scaffold wash-out.​</p>
<ol>
<li>Functional and Safety Quality Control</li>
</ol>
<p>Before any use in vivo, at minimum:</p>
<p>Structural QC:</p>
<p>Immunostaining for cardiac markers (cTnT, α-actinin), connexin-43, and aligned sarcomeres.​</p>
<p>Functional QC:</p>
<p>Measure spontaneous or paced contraction amplitude and frequency.</p>
<p>Assess conduction velocity and responsiveness to pacing changes and pharmacological agents (e.g., isoproterenol).​</p>
<p>Genetic &amp; safety QC:</p>
<p>Karyotype or chromosomal microarray on source cells and, periodically, on expanded populations.​</p>
<p>Assays for residual undifferentiated iPSCs (e.g., OCT4/NANOG expression) to reduce teratoma risk.​</p>
<p>This is the baseline “Heart v1.0” manual: if you follow these parameters—cell source, PGS/ECM-like scaffold, IGF-1 + ascorbate medium, 1 Hz pacing at 5 V/cm from day 3 in a low-shear perfusion bioreactor—you obtain a synchronously contracting cardiac construct with documented improvements in structure and function compared to unstimulated controls.</p>
<p><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC4698189/">1</a></p>
<p><a href="https://www.reprocell.com/clinical-stem-cell-services/gmp-ipsc-production">2</a></p>
<p><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC9934414/">3</a></p>
<p><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC3946629/">4</a></p>
<p><a href="https://www.sciencedirect.com/science/article/am/pii/S1931524422001827">5</a></p>
<p><a href="https://www.frontiersin.org/journals/bioengineering-and-biotechnology/articles/10.3389/fbioe.2025.1531731/full">6</a></p>
<p><a href="https://pubs.acs.org/doi/10.1021/acsbiomaterials.3c00756">7</a></p>
<p><a href="https://analyticalsciencejournals.onlinelibrary.wiley.com/doi/10.1002/biot.70116">8</a></p>
<p><a href="https://www.nature.com/articles/s41392-022-01024-9">9</a></p>
<p><a href="https://www.nature.com/articles/s41536-021-00140-4">10</a></p>
<ol>
<li>System overview and prerequisites</li>
</ol>
<p>Goal: Manufacture a patient-specific, vascularized, electromechanically functional heart suitable for eventual transplantation, using:</p>
<p>A whole-organ scaffold (preferably decellularized heart).​</p>
<p>Autologous or HLA-engineered human cells (iPSC-derived).​</p>
<p>A closed, perfused bioreactor with integrated electrical and mechanical conditioning.​</p>
<p>Preconditions:</p>
<p>Access to GMP-grade iPSC generation and differentiation pipelines.​</p>
<p>Access to decellularized porcine or donor human hearts, prepared under validated protocols.​</p>
<p>A perfusion–electrical stimulation bioreactor capable of coronary perfusion, chamber loading, and long-term sterile culture.​</p>
<ol>
<li>Step 1 – Scaffold: produce a patient-matched heart shell</li>
</ol>
<p>2.1 Choose scaffold strategy</p>
<p>Option A – Decellularized donor heart (preferred now):</p>
<p>Use whole-organ perfusion decellularization: perfuse detergents (e.g., SDS, Triton X-100) and DNase through coronary arteries and chambers at controlled pressures until DNA content and cell markers drop below thresholds while ECM composition and mechanics are preserved.​</p>
<p>Reviews show that perfusion-based decellularization best maintains native 3D architecture and microvasculature, forming the current gold standard for cardiac scaffolds.​</p>
<p>Option B – 3D-printed matrix:</p>
<p>Use a high-resolution CT/MRI of the patient heart to 3D print a soft replica from biodegradable, ECM-compatible materials, and seed it with patient-derived ECM “bio-ink” (as demonstrated for small, rabbit-sized hearts).​</p>
<p>At present this has been done only at reduced scale (∼100× smaller than human), but it proves feasibility of patient-matched geometry and composition.​</p>
<p>2.2 Scaffold validation</p>
<p>Confirm decellularization by DNA quantification, histology, and immunostaining for cellular antigens.​</p>
<p>Confirm preservation of collagen, elastin, and GAGs, plus mechanical properties (stress–strain curves) comparable to native myocardium and valves.​</p>
<p>Mount the acellular heart in a closed, sterile perfusion loop ready for recellularization.​</p>
<ol>
<li>Step 2 – Build cell banks and recellularization plan</li>
</ol>
<p>3.1 Generate cell populations</p>
<p>From autologous iPSCs or compatible donor cells, generate under GMP:​</p>
<p>Cardiomyocytes (ventricular-type hiPSC-CMs).</p>
<p>Conduction system cells (Purkinje-like cells) if available.</p>
<p>Endothelial cells for vascular and valvular surfaces.</p>
<p>Smooth muscle cells for vessel walls.</p>
<p>Cardiac fibroblasts for ECM support and mechanical integrity.</p>
<p>Each line must have:</p>
<p>Normal karyotype and negative panel for common oncogenic mutations.​</p>
<p>Defined differentiation protocols and surface marker profiles.​</p>
<p>3.2 Recellularization phases</p>
<p>Phase 1 – Re-endothelialization (internal “skin”):</p>
<p>Perfuse endothelial cells via multiple routes (e.g., combined inferior vena cava + brachiocephalic artery infusion) to seed both arterial and venous trees, as combined routes improved re-endothelialization in decellularized hearts.​</p>
<p>Maintain pulsatile perfusion at sub-physiological pressures initially, with pro-angiogenic factors (VEGF, bFGF) in the medium to support adhesion and spreading.​</p>
<p>Aim: continuous, confluent endothelial coverage of all luminal surfaces (chambers, valves, vessels), verified by histology and perfusion imaging.​</p>
<p>Phase 2 – Myocardial seeding (the pump layer):</p>
<p>Introduce cardiomyocytes (plus fibroblasts) through coronary perfusion and, where needed, controlled intramural injections guided by imaging to populate transmural wall thickness.​</p>
<p>Use cell densities and ratios informed by engineered cardiac tissue studies (e.g., CM:fibroblast:endothelial mixtures) that support synchronous contraction.​</p>
<p>Allow initial static attachment and low-flow perfusion to prevent washout.​</p>
<p>Phase 3 – Valves and conduction system:</p>
<p>Seed valve leaflets and annuli with valve interstitial and endothelial cells (or appropriate progenitors) to restore viable, remodelable valves, following decellularized valve recellularization practice.​</p>
<p>Where protocols exist, place conduction cells along native conduction pathways to recreate rapid impulse propagation; otherwise, rely on well-coupled CM networks and later electrical entrainment.​</p>
<ol>
<li>Step 3 – Bioreactor conditioning: turning a seeded scaffold into a heart</li>
</ol>
<p>4.1 Perfusion and mechanical loading</p>
<p>Use a bioreactor that combines interstitial perfusion with coronary perfusion and chamber loading; studies show that bidirectional interstitial flow plus perfusion improves distribution, viability, and synchronous contraction.​</p>
<p>Gradually ramp coronary flow, chamber filling, and afterload from minimal to near-physiologic levels over weeks, maintaining wall shear and pressures in safe ranges for immature tissues.​</p>
<p>4.2 Electrical stimulation</p>
<p>Integrate electric field stimulation into the perfusion bioreactor; prior work used 1 Hz, 2 ms bipolar pulses at current densities around 70–75 mA/cm² or equivalent fields to enhance elongation, sarcomeric striation, and connexin-43 expression in constructs.​</p>
<p>Practical starting protocol (adapted from scaffolds and bioreactor studies):​</p>
<p>Start once cells are attached (a few days after seeding).</p>
<p>1 Hz monophasic or biphasic pulses.</p>
<p>1–5 V/cm effective field strength, 2 ms duration.</p>
<p>Increase frequency and complexity only as tissue matures and handles load.</p>
<p>Studies of perfused, electrically stimulated cardiac constructs consistently show lower excitation thresholds, more uniform and stronger contractions, and better molecular maturation versus unstimulated controls.​</p>
<p>4.3 Metabolic and structural maturation</p>
<p>Over several weeks, adjust medium composition from glycolytic, fetal-like to more adult-like (fatty-acid-rich substrates, thyroid and other hormones) in line with cardiac maturation literature.​</p>
<p>Continue electromechanical “training,” monitoring:</p>
<p>Contractile output (pressure, ejection fraction surrogate, force).​</p>
<p>Conduction velocity and arrhythmia susceptibility.​</p>
<p>Valve competence under pulsatile flow.​</p>
<ol>
<li>Step 4 – Quality control, release, and surgical integration</li>
</ol>
<p>Before any consideration of implantation, the construct must pass rigorous release criteria, aligning with regenerative medicine and transplant engineering guidance:</p>
<p>Structural and molecular:</p>
<p>Histology confirming viable myocardium through full wall thickness, intact ECM, and confluent endothelium in all major vessels and valves.​</p>
<p>Immunostaining for cardiac markers (cTnT, α-actinin), gap junction proteins (connexin-43), and absence of pluripotency markers (OCT4, NANOG).​</p>
<p>Functional:</p>
<p>Stable, synchronous contractions under variable pacing rates without sustained arrhythmia.​</p>
<p>Hemodynamic testing in vitro: ability to generate physiologic pressures and flows in a mock circulation loop.​</p>
<p>Competent, non-regurgitant valve function under pulsatile loading.​</p>
<p>Safety and regulatory:</p>
<p>Sterility and mycoplasma tests per GMP.​</p>
<p>Confirmed genomic stability (karyotype, targeted sequencing) of key cell populations after expansion and culture.​</p>
<p>Compliance with ATMP/ISSCR and national regulatory guidelines for stem-cell derived implantable products.​</p>
<p>Decellularized whole-heart scaffolds and valves</p>
<p>****​
Frontiers in Bioengineering and Biotechnology – “Decellularization Strategies for Regenerating Cardiac and Skeletal Muscle.” Overview of whole-organ decellularization protocols, detergents, pressures, and ECM preservation for heart scaffolds.</p>
<p>****​
The Quest for an Optimized Protocol for Whole-Heart Decellularization. Compares perfusion-based decellularization methods and criteria (DNA content, ECM integrity).</p>
<p>****​
Frontiers in Bioengineering and Biotechnology – “Decellularization in Tissue Engineering and Regenerative Medicine.” General review, including heart and large organs.</p>
<p><strong>** / </strong>]​
“Decellularized scaffolds and heart valve treatment.” Reviews decellularized heart valves, recellularization, and functional testing.</p>
<p>****​
“Recellularization of decellularized heart valves.” Methods and challenges for reseeding valves with viable cells.</p>
<p>Whole-heart engineering and current status</p>
<p>****​
NIH/PMC – “Whole-Heart Tissue Engineering and Cardiac Patches.” 2023 review summarizing decellularized hearts, recellularization attempts, and status of whole-organ approaches.</p>
<p>****​
“Is a Bioengineered Heart From Recipient Tissues the Answer…?” Review of feasibility and challenges for clinically usable bioengineered hearts.</p>
<p>****​
“Current research trends and challenges in tissue engineering for cardiac regeneration.” Broad overview of limitations (vascularization, maturation, arrhythmias).</p>
<p>****​
“Challenges and opportunities for the next generation of cardiac tissue engineering.” Discusses maturity, integration, and translation barriers.</p>
<p>Angiogenesis and re-endothelialization</p>
<p>****​
Frontiers in Bioengineering and Biotechnology – “Angiogenesis and Re-endothelialization in Decellularized Scaffolds.” Mechanisms and strategies for re-lining vascular trees, including combined infusion routes.</p>
<p>Cardiac patches, scaffolds, and electrical stimulation</p>
<p>****​
NIH/PMC – “Biomimetic scaffold combined with electrical stimulation and growth factor release for cardiac tissue engineering.” PGS scaffold, IGF-1 + ascorbate, 1 Hz, 5 V/cm electrical conditioning.</p>
<p>****​
NIH/PMC – “Cardiac tissue engineering using perfusion bioreactor systems.” Early but foundational work on perfusion bioreactors for cardiac constructs.</p>
<p><strong><em>* / ** </em></strong>*​
“Electric Field Stimulation Integrated into Perfusion Bioreactor for Cardiac Constructs” and follow-ups – parameters and effects of electric field stimulation plus perfusion on cardiac tissues.</p>
<p>****​
Scientific Reports – “Enhancing all-in-one bioreactors by combining interstitial perfusion and electrical stimulation.” Shows benefits of combined perfusion + E-field for engineered cardiac tissues.</p>
<p><strong><em>* / ** </em></strong>*​
Frontiers in Bioengineering and Biotechnology – “Versatile electrical stimulator for cardiac tissue engineering” and “Novel, low-cost bioreactor for in vitro electrical stimulation of cardiac tissue.” Bioreactor hardware and pacing setups.</p>
<p>Cardiac tissue engineering &amp; organoids</p>
<p>****​
Biotechnology Journal – “Recent Advances in Cardiac Tissue Engineering: Innovations and Future Directions.” Summarizes scaffold, cell, and bioreactor strategies.</p>
<p>****​
Frontiers in Bioengineering and Biotechnology – “Cardiac tissue engineering: an emerging approach to the treatment of heart disease.”</p>
<p>****​
“Engineering approaches for cardiac organoid formation and their applications.” Cardiac organoids, 3D models, and patterning.</p>
<p><strong><em>* / ** </em></strong>*​
Reviews on cardiac tissue-derived ECM scaffolds, soluble decellularized ECM, and their use for myocardial regeneration.</p>
<p>3D-printed hearts / patient-specific scaffolds</p>
<p><strong><em>* / ** </em></strong>*​
News reports and institutional releases on Tel Aviv University’s 3D-printed, cell-laden rabbit-scale heart using patient-derived matrix and cells.</p>
<p>****​
Tel Aviv University – “TAU scientists print first ever 3D heart using patient's own cells.” Institutional summary.</p>
<p>****​
Futures Platform – “We Now Have 3D-Printed Human Hearts.” Overview of 3D-printed heart replicas and their status.</p>
<p>****​
MIT News – “Custom, 3D-printed heart replicas look and pump just like the real thing.” Patient-specific physical replicas for planning/simulation.</p>
<p>Regenerative and regulatory context</p>
<p>****​
Nature – “Human organoids in basic research and clinical applications.” Sets context for organoid-based organ engineering.</p>
<p>****​
Nature – “Next generation of heart regenerative therapies: progress and challenges.” Links heart tissue engineering with clinical translation pipelines.</p>
<p>****​
NIH/PMC – “Current good manufacturing practice considerations for cell therapy and regenerative medicine products.” GMP and QC framework.</p>
<p>****​
ISSCR Guidelines – “Guidelines for Stem Cell Research and Clinical Translation.” Ethics and regulatory principles.</p>
<p>****​
JAMA Surgery – “Tissue Engineering: Toward New Solutions for Transplantation and Reconstructive Surgery.” General transplant-engineering outlook.</p>
<p>https://www.frontiersin.org/journals/bioengineering-and-biotechnology/articles/10.3389/fbioe.2022.831300/full</p>
<p>https://pmc.ncbi.nlm.nih.gov/articles/PMC9855348/</p>
<p>https://www.nature.com/articles/s41392-022-01024-9</p>
<p>https://www.nature.com/articles/s41536-021-00140-4</p>
<p>https://www.nature.com/articles/s41598-018-35019-w</p>
<p>https://pubmed.ncbi.nlm.nih.gov/20367291/</p>
<p>https://pmc.ncbi.nlm.nih.gov/articles/PMC2763607/</p>
<p>https://www.reprocell.com/clinical-stem-cell-services/gmp-ipsc-production</p>
<p>https://pmc.ncbi.nlm.nih.gov/articles/PMC9934414/</p>
<p>https://journals.sagepub.com/doi/full/10.1089/ten.tec.2011.0210</p>
<p>https://www.frontiersin.org/journals/bioengineering-and-biotechnology/articles/10.3389/fbioe.2022.805299/full</p>
<p>https://ieeexplore.ieee.org/document/6610974</p>
<p>http://www.xinhuanet.com/english/2019-04/16/c_137979905.htm</p>
<p>https://english.tau.ac.il/news/printed_heart</p>
<p>https://www.futuresplatform.com/blog/3d-printed-human-hearts</p>
<p>https://www.nbcnews.com/mach/science/israeli-scientists-create-world-s-first-3d-printed-heart-using-ncna996031</p>
<p>https://news.mit.edu/2023/custom-3d-printed-heart-replicas-patient-specific-0222</p>
<p>https://pmc.ncbi.nlm.nih.gov/articles/PMC6799998/</p>
<p>https://pmc.ncbi.nlm.nih.gov/articles/PMC9978201/</p>
<p>https://journals.plos.org/plosone/article?id=10.1371%2Fjournal.pone.0090406</p>
<p>https://pmc.ncbi.nlm.nih.gov/articles/PMC5574480/</p>
<p>https://academic.oup.com/rb/article/6/4/185/5476194</p>
<p>https://pmc.ncbi.nlm.nih.gov/articles/PMC3946629/</p>
<p>https://analyticalsciencejournals.onlinelibrary.wiley.com/doi/10.1002/biot.70116</p>
<p>https://pmc.ncbi.nlm.nih.gov/articles/PMC4698189/</p>
<p>https://www.sciencedirect.com/science/article/pii/S2772950825001943</p>
<p>https://pubmed.ncbi.nlm.nih.gov/40505382/</p>
<p>https://www.frontiersin.org/journals/bioengineering-and-biotechnology/articles/10.3389/fbioe.2024.1441933/full</p>
<p>https://onlinelibrary.wiley.com/doi/abs/10.1002/term.525</p>
<p>https://www.frontiersin.org/journals/bioengineering-and-biotechnology/articles/10.3389/fbioe.2022.1031183/full</p>
<p>https://pmc.ncbi.nlm.nih.gov/articles/PMC12061062/</p>
<p>https://onlinelibrary.wiley.com/doi/10.1002/jbm.b.35686</p>
<p>https://www.frontiersin.org/journals/bioengineering-and-biotechnology/articles/10.3389/fbioe.2022.802283/full</p>
<p>https://pmc.ncbi.nlm.nih.gov/articles/PMC9132496/</p>
<p>https://www.isscr.org/guidelines</p>
<p>https://jamanetwork.com/journals/jamasurgery/fullarticle/390428</p>
<p>https://www.ovid.com/journals/ctorg/pdf/10.1159/000511382~whole-heart-engineering-advances-and-challenges</p>
<p>https://journals.sagepub.com/doi/10.1089/ten.tec.2010.0068?icid=int.sj-abstract.similar-articles.2</p>
<p>https://www.facebook.com/IsraelinSouthAfrica/posts/israeli-scientists-at-tel-aviv-university-have-3d-printed-a-living-beating-human/1285844023584938/</p>
                
<div class="footer-warning">
    <strong>© IL WOONG CHOI / CODEX OF COSMOS 2025. All Rights Reserved.</strong><br>
    This work is licensed under a <a href="http://creativecommons.org/licenses/by-nc-nd/4.0/" target="_blank" style="color:#777;">Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License</a>.<br>
    Unauthorized reproduction, distribution, or modification of this material is a violation of international copyright law.<br>
    <span style="color: red;">WARNING: This site employs digital rights management (DRM) protocols. Any attempt to scrape, copy, or extract data is monitored.</span>
</div>

            </div>
            </body></html>